TENOFOVIR DISOPROXIL + EMTRICITABINE
tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30
TENOFOVIR DISOPROXIL + EMTRICITABINE (15383P)
15383P
Manner of administration:Oral
Restriction
Indication: Pre-exposure prophylaxis (PrEP) against human immunodeficiency virus (HIV) infection
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 2 | DPMQ: $56.08 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||